Jeong-Won Park
Fortune : 84 107 $ au 31/05/2026
Fortune : 84 107 $ au 31/05/2026
Mr. Jeong-Won Park is Vice President at Neoplux Co., Ltd.
Prior to joining Neoplux, he worked at Nomura Securities, Lehman Brothers, Macquarie Bank, focusing primarily on Korea M&A.
Mr.Park holds a BS from Seoul National University in Sociology and is also a US CPA and FRM.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
InkTec Co., Ltd.
InkTec Co., Ltd. Computer PeripheralsElectronic Technology Manufactures and sells consumables for printers 0,2 % | 30/01/2026 | 39 000 ( 0,2 % ) | 84 107 $ | 31/05/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| ST PHARM CO.,LTD. | Directeur/Membre du Conseil | - |
Shinhan Venture Investment Co. Ltd.
Shinhan Venture Investment Co. Ltd. Investment ManagersFinance Shinhan Venture Investment seeks to invest in companies located in South Korea. The firm target companies operating in the fields of aging population, disruptive technologies, IT convergence, alternative energy, ICT, bio/healthcare, contents/gaming, industrials, power/energy and consumer/retail. The firm providing financing for early, growth, buyout, PIPE and secondaries capital requirements. | Private Equity Investor | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
Shinhan Venture Investment Co. Ltd.
Shinhan Venture Investment Co. Ltd. Investment ManagersFinance Shinhan Venture Investment seeks to invest in companies located in South Korea. The firm target companies operating in the fields of aging population, disruptive technologies, IT convergence, alternative energy, ICT, bio/healthcare, contents/gaming, industrials, power/energy and consumer/retail. The firm providing financing for early, growth, buyout, PIPE and secondaries capital requirements. | Finance |
Seoul National University
Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ST Pharm Co., Ltd.
ST Pharm Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops active pharmaceutical ingredients and intermediates | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national